Glecirasib in KRASG12C-mutated nonsmall-cell lung cancer: a phase 2b trialYuankai Shi, Zhiyue Rao, Jian Zhang et al.|Nature Medicine|2025Cited by 30
Cytotoxicity mechanism of α-MMC in normal liver cells through LRP1 mediated endocytosis and JNK activationLing Wang, Xiaolan Liu, Fubing Shen et al.|Toxicology|2016Cited by 22